Home Basal ganglia infarction and COVID-19 infection in an elderly patient: A case report
Article Open Access

Basal ganglia infarction and COVID-19 infection in an elderly patient: A case report

  • Manar Ahmed Kamal ORCID logo EMAIL logo
Published/Copyright: November 5, 2021
Become an author with De Gruyter Brill

Abstract

Background

Coronavirus disease 2019 (COVID-19) has spread rapidly worldwide since the first cases were observed in Wuhan, China. Patients with COVID-19 develop multiple neurological symptoms, including headache, disturbed consciousness, and paresthesia, in addition to systemic and respiratory symptoms.

Case presentation

We presented a 57-year-old woman admitted to the emergency department – in December 2020 – with complaints of slurred speech, confusion, and left upper limb weakness after one week of positive nasopharyngeal swab sample SARS-CoV-2.

Conclusions

While the patient had previous comorbidities like hypertension and diabetes, she had no prior history of ischemic stroke or thrombosis, so we conclude that unilateral acute basal ganglia infarction may be a unique neurological manifestation after COVID-19 infection in an elderly patient with previous comorbidities.

1 Background

Coronavirus disease 2019 (COVID-19) is a novel disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 has spread rapidly worldwide since the first cases in Wuhan, China, were observed in December 2019 [1]. Patients with COVID-19 develop neurological symptoms, including headache, disturbed consciousness, and paresthesia [2], in addition to systemic and respiratory symptoms. Stroke is one of the most typical neurological manifestations associated with COVID-19 [3,4]. Also, basal ganglia hemorrhage [5,6] and altered mental status are neurological manifestations of coronavirus disease 2019 [5]. We describe a case of basal ganglia infarction associated with COVID-19 in a female elderly patient. The report is early published as a preprint in Research Square [7].

2 Case presentation

A 57-year-old woman presented to the emergency department (ED) – in December 2020 – with complaints of slurred speech, confusion, and left upper limb weakness. Her medical history included suffering from a persistent fever, severe headache, cough, fatigue, anosmia, dysgeusia, sore throat, vomiting, dizziness, fatigue, and bony pain, and the reverse transcription-polymerase chain reaction (RT-PCR) assay of nasopharyngeal swab sample was positive for SARS-CoV-2 from one week before presentation in ED. The patient also has diabetes mellites and hypertension in her medical history. All routine diagnostic tests were done, and the patient’s blood analysis showed an increase in red blood cells (RBCs), lymphocytes count, a marked increase in C-reactive protein (CRP), and D-dimer due to infection. She had a slightly decreasing mean corpuscular hemoglobin concentration and a marked increase in fasting blood glucose (FBS) as diabetes (Table 1). The patient weight was 70 kg; height: 150 cm; body mass index (BMI): 31 kg/m2; and the blood pressure: 140/100 mm Hg sitting. The pulse was 90/min, and oxygen saturation was 90%. Chest computed tomography (CT) and magnetic resonance imaging (MRI) on the brain were done for the patient. CT of the lung showed few right-side apical small ground-glass consolidation patches with bilateral mild subpleural lower lobar ground-glass haze more accentuated on the right side that scientifically reefed to right-side viral pneumonia because of COVID-19. Few scattered sub-centimetric emphysematous bullae were noted with fine scattered subpleural atelectatic bands. Mediastinal structures are normal with a patent tracheobronchial tree. There is no mediastinal, hilar adenopathy, or pleural effusion (Figure 1). The scanned arterial tree, including the coronary vessels, involved advanced atherosclerotic changes and mild to moderate cardiac chamber enlargement. Visualized cuts of the upper abdomen revealed a well-defined right adrenal lesion with internal fat density measuring about 5.2 cm × 4 cm, primarily representing fat-rich adenoma with few bilateral simple cortical renal cysts (Figure 1).

Table 1

Laboratory tests and examinations

Laboratory tests Patient-level Normal level Unit
Complete blood count (CBC)
  Hemoglobin (Hb) 13.2 12–16 g/dL
  RBCs 5.39 3.8–4.8 ×106/UL
  HCT 45.1 36–46 L/L
  MCV 83.7 80–101 Fl
  MCH 26.5 26–32 Pg
  MCHC 29.3 31–34 g/dL
  Platelet count 337 150–400 ×103/µL
  WBCs 6.5 4–11 ×103/µL
Differential leucocyte count
  Neutrophils 45 40–80 %
    1. Staff 3 0–8 %
    2. Segmented 42 40–75 %
  Lymphocytes 45 20–40 %
  Monocytes 8 2–10 %
  Eosinophils 2 1–6 %
  Basophils 0 0–1 %
  INR 1.02 1–3
  Serum creatinine 0.9 0.6–1.10 mg/dL
  S.G.O.T (AST) 32 Up to 40 U/L
  S.G.P.T (ALT) 38 Up to 40 U/L
  FBS 238 99 or lower mg/dL
  CRP 31.7 below 3.0 mg/L
  D-dimer 0.720 below 0.500 ng/mL
  Ferritin 109.9 12–263 ng/mL

The patient’s blood analysis showed an increase in RBCs, lymphocyte count, a marked increase in CRP, and a slight increase of D-dimer due to infection. In addition, she had a slight decrease in mean corpuscular hemoglobin concentration and a significant rise in FBS as she has diabetes.

Abbreviations: RBCS: blood red blood cells (erythrocytes); HCT: hematocrit; MCV: mean corpuscular volume; MCH: mean corpuscular hemoglobin; MCHC: mean corpuscular hemoglobin concentration; MPV: mean platelet volume; WBCS: white blood cells; INR: the international normalized ratio; SGOT: serum glutamic oxaloacetic transaminase; AST: aspartate aminotransferase; SGPT: serum glutamic pyruvic transaminase; ALT: alanine aminotransferase; FBS: fasting blood glucose; CRP: C-reactive protein.

Figure 1 
               Computerized tomography (CT) on the lung. Multiple axial contiguous thin cuts were taken through the chest and have shown few right-side apical small ground-glass consolidation patches with bilateral mild subpleural lower lobar ground-glass haze more accentuated on the right side; in addition to mild to moderate cardiomegaly and right adrenal lesion with fat-rich adenoma.
Figure 1

Computerized tomography (CT) on the lung. Multiple axial contiguous thin cuts were taken through the chest and have shown few right-side apical small ground-glass consolidation patches with bilateral mild subpleural lower lobar ground-glass haze more accentuated on the right side; in addition to mild to moderate cardiomegaly and right adrenal lesion with fat-rich adenoma.

Brain MRI showed acute infarction of the right basal ganglia (Figure 2) and abnormal hyperintense signal along with the right caudate head and anterior limb of the internal capsule in (a) fluid-attenuated inversion recovery (FLAIR) sequence (arrow) associated with positive mass effect on the right lateral ventricle. The corresponding area of restricted diffusion was appreciated as a hyperintense signal in (b) diffusion-weighted imaging (DWI) and hypointense signal in (c) apparent diffusion coefficient (ADC) denoting restricted distribution in the DWI and ADC map, (d) perfusion-weighted imaging (PWI) showing corresponding markedly reduced perfusion in the affected area (circle) impressive of right caudate head/anterior limb of internal capsule acute infarction. The images were imported into the viewing software (OsiriX Lite®).

Figure 2 
               MRI on the brain. MRI on the brain has shown acute right basal ganglia infarct. (a) FLAIR, (b) DWI, (c) ADC, and (d) PWI.
Figure 2

MRI on the brain. MRI on the brain has shown acute right basal ganglia infarct. (a) FLAIR, (b) DWI, (c) ADC, and (d) PWI.

Intravenous recombinant tissue plasminogen activator (rt-PA) was given to patients within 3 hours after onset. In addition to starting the COVID-19 therapeutic course, the decision was taken to admit the patient to an intensive care unit (ICU) until stabilizing O2 saturation. We treated the patient with intravenous ceftriaxone (2 g/day for 14 days), methylprednisolone (60 mg daily over six months), and anticoagulation over three months. Symptoms resolved entirely within 72 h. The patient was discharged after two weeks of antibiotic therapy. During a follow-up period of two weeks, no new symptoms occurred, and the second nasopharyngeal swab by RT-PCR assay was negative for SARS-CoV-2.

  1. Informed consent: Informed consent has been obtained from all individuals included in this study.

  2. Ethical approval: The research related to human use has been complied with all the relevant national regulations, institutional policies, and in accordance with the tenets of the Helsinki Declaration and has been approved by the Research Ethical Committee (REC) in the Faculty of Medicine – Benha University, Egypt (Ethical Approval Number: RC.10.1.2021).

3 Discussion

Basal ganglia infarction is a rare type of cerebral infarct with unique clinical manifestations [8]. As in this report, many factors may lead to basal ganglia infarction, including diabetes mellites [9] and recently COVID-19. Among patients with diabetes, the risk of vascular events is significantly increased compared to nondiabetics [9]. The patient was a confirmed case of SARS-CoV-2 Infection, which agrees with the evidence that elderly patients are more susceptible to infection [10]. Our patient developed right-sided viral pneumonia, a significant cause of death in patients with cerebral infarction. Nakagawa and colleagues showed that the pneumonia mortality rate in patients with basal ganglia infarcts was significantly higher than in patients with or without cerebral hemispheric strokes in other locations [11]. Due to right-sided viral pneumonia, the patient was admitted to ICU to protect her life. There is ample evidence that COVID-19 may be associated with many neurological conditions [4] such as stroke [3], facial nerve palsy [12], Guillain-Barré syndrome [13], and basal ganglia hemorrhage [5,6]. A case series conducted in 2020 on 3,556 hospitalized patients with a diagnosis of COVID-19 infection showed that the incidence of ischemic stroke in COVID-19 patients was relatively lowered; 32 patients (0.9%) had imaging proven ischemic stroke [14], while Tan and colleagues report that the pooled incidence of acute ischemic stroke (AIS) in COVID-19 patients was about 1.2%, with a high mortality rate [3]. However, the underlying stroke mechanism of COVID-19 remains debatable [3]. Elevated D-dimer is prominent in COVID-19 patients with concomitant ischemic stroke, but further mechanistic studies are required to elucidate their role in the pathogenesis of AIS. However, multiple studies described neurological complications of COVID-19; no previous evidence presented the association between basal ganglia infarction and COVID-19 infection.

4 Conclusions

While the patient had previous comorbidities like hypertension and diabetes, she had no prior history of ischemic stroke or thrombosis, so we conclude that unilateral acute basal ganglia infarction may be a unique neurological manifestation after COVID-19 infection in an elderly patient with previous comorbidities. The most predicted mechanism depends mainly on D-dimer changes. The learned Lesson of this case report is the rapid bringing of the patient if they have any of the following symptoms (FAST): F: Facial drooping, A: Arm weakness, S: Speech difficulties, and T: Time to call for an emergency. The learned Lesson for doctors is accurate medical history-taking and rapid.

List of abbreviations

COVID-19

coronavirus disease 2019

ED

emergency department

SARS-CoV-2

severe acute respiratory syndrome coronavirus 2

RT-PCR

reverse transcription-polymerase chain reaction

RBCs

red blood cells

CRP

C-reactive protein

FBS

fasting blood glucose

BMI

body mass index

CT

chest computed tomography

MRI

magnetic resonance imaging

rt-PA

intravenous recombinant tissue plasminogen activator

ICU

intensive care unit

AIS

acute ischemic stroke

FAST: F

facial drooping

A

arm weakness

S

speech difficulties

T

time to call for an emergency


,
tel: +20-112-282-6853

Acknowledgment

I am glad to send a direct, special thanks to Prof. Dr. Huda Abdalla El-Sayed Ramadan, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt, for her unending support and encouragement.

  1. Conflict of interest: Authors state no conflict of interest.

  2. Data availability statement: The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

[1] Oran DP, Topol EJ. Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review. Ann Intern Med. 2020;173(5):362–7.10.7326/M20-3012Search in Google Scholar PubMed PubMed Central

[2] Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020 Jul;87:18–22.10.1016/j.bbi.2020.03.031Search in Google Scholar PubMed PubMed Central

[3] Tan YK, Goh C, Leow AST, Tambyah PA, Ang A, Yap ES, et al. COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature. J Thromb Thrombolysis. 2020;50(3):587–95.10.1007/s11239-020-02228-ySearch in Google Scholar PubMed PubMed Central

[4] Whittaker A, Anson M, Harky A. Neurological manifestations of COVID-19: a systematic review and current update. Acta Neurol Scand. 2020;142(1):14–22.10.1111/ane.13266Search in Google Scholar PubMed PubMed Central

[5] Haddadi K, Ghasemian R, Shafizad M. Basal ganglia involvement and altered mental status: a unique neurological manifestation of coronavirus disease 2019. Cureus. 2020;12(4):4–9.10.7759/cureus.7869Search in Google Scholar PubMed PubMed Central

[6] Daci R, Kennelly M, Ferris A, Azeem MU, Johnson MD, Hamzei-Sichani F, et al. Bilateral basal ganglia hemorrhage in a patient with confirmed COVID-19. Am J Neuroradiol. 2020;41(10):1797–9.10.3174/ajnr.A6712Search in Google Scholar PubMed PubMed Central

[7] Kamal MA. Basal ganglia infarction a rare neurological manifestation of COVID-19 in an elderly patient: a case report. 10.21203/rs.3.rs-553242/v1.Search in Google Scholar

[8] Wagner SJ, Begaz T. Basal ganglion stroke presenting as subtle behavioural change. Emerg Med J. 2008;25(7):459.10.1136/emj.2008.057968Search in Google Scholar PubMed

[9] Gutierrez J, Esenwa C. Secondary stroke prevention: challenges and solutions. Vasc Health Risk Manag. 2015 Aug;11:437.10.2147/VHRM.S63791Search in Google Scholar PubMed PubMed Central

[10] Kamal MA, Alamiry KR, Zaki M. Sex and age differences in telomere length and susceptibility to COVID-19. J Biomed Res Environ Sci [Internet]. 2020 Nov;1(7):303–10. Available from: https://www.jelsciences.com/articles/jbres1159.10.37871/jbres1159Search in Google Scholar

[11] Nakagawa J, Sekizawa K, Aral H, Kikuchi R, Manabe K, Sasaki H. High incidence of pneumonia in elderly patients with basal ganglia infarction. Arch Intern Med. 1997;157(3):321–4.10.1001/archinte.1997.00440240085013Search in Google Scholar

[12] Codeluppi L, Venturelli F, Rossi J, Fasano A, Toschi G, Pacillo F, et al. Facial palsy during the COVID-19 pandemic. Brain Behav. 2021;11(1):1–5.10.1002/brb3.1939Search in Google Scholar PubMed PubMed Central

[13] Uncini A, Vallat JM, Jacobs BC. Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic. J Neurol Neurosurg Psychiatry. 2020;91(10):1105–10.10.1136/jnnp-2020-324491Search in Google Scholar PubMed

[14] Yaghi S, Ishida K, Torres J, Mac Grory B, Raz E, Humbert K, et al. SARS-CoV-2 and stroke in a New York healthcare system. Stroke. 2020 Jul;51(7):2002–11.10.1161/STROKEAHA.120.030335Search in Google Scholar PubMed PubMed Central

Received: 2021-09-25
Revised: 2021-10-13
Accepted: 2021-10-13
Published Online: 2021-11-05

© 2021 Manar Ahmed Kamal, published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Research Articles
  2. Ulinastatin alleviates traumatic brain injury by reducing endothelin-1
  3. IKBIP is a novel EMT-related biomarker and predicts poor survival in glioma
  4. Pelargonidin ameliorates MCAO-induced cerebral ischemia/reperfusion injury in rats by the action on the Nrf2/HO-1 pathway
  5. Vertebral plate and ligament composite laminoplasty in spinal cord tumor surgery: Analysis of 94 patients
  6. Anti-inflammatory genes in PBMCs post-spontaneous intracerebral hemorrhage
  7. Calumenin contributes to epithelial-mesenchymal transition and predicts poor survival in glioma
  8. The effect of dietary supplementation with high- or low-dose omega-3 fatty acid on inflammatory pathology after traumatic brain injury in rats
  9. Dysregulated gene-associated biomarkers for Alzheimer’s disease and aging
  10. Inhibition of lncRNA H19/miR-370-3p pathway mitigates neuronal apoptosis in an in vitro model of spinal cord injury (SCI)
  11. Euxanthone inhibits traumatic spinal cord injury via anti-oxidative stress and suppression of p38 and PI3K/Akt signaling pathway in a rat model
  12. Role of exosomal miRNAs in brain metastasis affected by radiotherapy
  13. Resveratrol against 6-OHDA-induced damage of PC12 cells via PI3K/Akt
  14. A new surgical method of treatment spontaneous intracranial hemorrhage
  15. Chronic restraint stress impairs cognition via modulating HDAC2 expression
  16. Naringin attenuates cerebral ischemia-reperfusion injury in rats by inhibiting endoplasmic reticulum stress
  17. Intracerebral hemorrhage with tentorial herniation: Conventional open surgery or emergency stereotactic craniopuncture aspiration surgery?
  18. miR-380-5p facilitates NRF2 and attenuates cerebral ischemia/reperfusion injury-induced neuronal cell death by directly targeting BACH1
  19. Nervonic acid amends motor disorder in a mouse model of Parkinson’s disease
  20. Lepidium sativum as candidate against excitotoxicity in retinal ganglion cells
  21. circ_0030018 promotes glioma proliferation and metastasis
  22. Vitamin D3 reduces hippocampal NR2A and anxiety in nicotine withdrawal mice
  23. Frontoparietal anodal tDCS reduces ketamine-induced oscillopathies
  24. Tripchlorolide attenuates β-amyloid generation by inducing NEP activity in N2a/APP695 cells
  25. Canstatin represses glioma growth by inhibiting formation of VM-like structures
  26. WNK3 promotes the invasiveness of glioma cell lines under hypoxia by inducing the epithelial-to-mesenchymal transition
  27. miR-485-5p alleviates Alzheimer’s disease progression by targeting PACS1
  28. Toxic effects of formaldehyde and the protective effect of docosahexaenoic acid in Drosophila
  29. Chopstick operation training with the left non-dominant hand
  30. Labor Analgesia reduces the risk of postpartum depression: A cohort study
  31. Nicotine induced ototoxicity in rat cochlear organotypic cultures
  32. Altered cerebellum functional network on newly diagnosed drug-naïve Parkinson’s disease patients with anxiety
  33. Therapeutic value of the metabolomic active neurotransmitter isorhynchophylline in the treatment of spontaneously hypertensive rats by regulating neurotransmitters
  34. Risky decision-making following prefrontal D1 receptor manipulation
  35. Cerebrospinal fluid electrolytes and acid-base in diabetic patients
  36. circ_0082375 promotes the progression of glioma by regulating Wnt7B
  37. Cryptotanshinone ameliorates CUS-induced depressive-like behaviors in mice
  38. A novel strategy for driving car brain–computer interfaces: Discrimination of EEG-based visual-motor imagery
  39. Galvanic vestibular stimulation with low intensity improves dynamic balance
  40. Neuropeptide changes in an improved migraine model with repeat stimulations
  41. Neuroprotective effects of the Chrysophyllum perpulchrum extract against an Alzheimer-like rat model of β amyloid1-40 intrahippocampal injection
  42. Bone marrow mesenchymal stem cells overexpressing hepatocyte growth factor ameliorate hypoxic–ischemic brain damage in neonatal rats
  43. Leaky gut biomarkers in casein- and gluten-rich diet fed rat model of autism
  44. Altered sleep intensity upon DBS to hypothalamic sleep–wake centers in rats
  45. Review Articles
  46. The potential antiepileptogenic effect of neuronal Cx36 gap junction channel blockage
  47. Acupuncture and oxytocinergic system: The promising treatment for autism
  48. Hormones in experimental autoimmune encephalomyelitis (EAE) animal models
  49. Immunoregulation and antidepressant effect of ketamine
  50. Review: Pelvic nerves – from anatomy and physiology to clinical applications
  51. Sustained delivery of neurotrophic factors to treat spinal cord injury
  52. Benefits of vitamin D supplementation to attenuate TBI secondary injury?
  53. Effects of gut microbiota and probiotics on Alzheimer’s disease
  54. Functional roles of the microbiota-gut-brain axis in Alzheimer’s disease: Implications of gut microbiota-targeted therapy
  55. Commentary
  56. Evaluating the translational value of postmortem brain reperfusion technology
  57. Case Report
  58. A novel KCNT1 mutation in a Chinese family with severe autosomal-dominant nocturnal frontal lobe epilepsy
  59. Spinocerebellar ataxia type 40: A case report and literature review
  60. Basal ganglia infarction and COVID-19 infection in an elderly patient: A case report
  61. Rapid Communication
  62. Ultrasound-guided ethyl alcohol injection to the deep branch of the ulnar nerve to relieve hand spasticity in stroke patients: A case series
  63. Erratum
  64. Erratum to “Ulinastatin alleviates traumatic brain injury by reducing endothelin-1”
  65. Special Issue “Neuroinflammation: from basic to clinical perspectives”
  66. The clinical significance of glutathione peroxidase 2 in glioblastoma multiforme
Downloaded on 8.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/tnsci-2020-0194/html
Scroll to top button